ARCHIVES

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

Celgene Begins Two Studies With Hoffmann-La Roche.

June 29, 2001

Marijuana Ingredient Promotes Tumor Growth, Study Finds.

June 23, 2000

Huebner Retires, Named Scientist Emeritus

November 19, 1982

House Committee Allocates NCI $1.347 Billion, $189 Million Over President’s Request For 1987

August 1, 1986

Cancer Control RFA Announcements

March 9, 1979

NCAB Subcommittee Approves Concept Of Qualifying Minimums, Salary Support Limit For Core Grants

October 3, 1980